There are several barriers to optimising glycaemia in T1D, including integrating diabetes management into day‐to‐day life, fear of hypoglycaemia, insulin dose calculation, as well as the inconvenience of frequent self‐monitoring of blood glucose (SMBG) levels.7 This evidence concerns the gene INS and type 1 diabetes mellitus.